Orthocell Delivers Outstanding Results In Remplir Nerve Regeneration Trial

Orthocell delivers outstanding results in Remplir™ nerve regeneration trial

Proactive Investors

Remplir - Nerve repair

Just the Facts: Orthocell achieves FDA study milestone for Remplir™ nerve repair product

Proactive Investors

Just the Facts: Orthocell submits US FDA application for Remplir nerve repair product

Proactive Investors

Orthocell thrilled with positive nerve regeneration results

Proactive Investors

Orthocell publishes positive pre-clinical trial study for CelGro nerve repair

Proactive Investors

Orthocell Breakthrough: FDA Study Validates Remplir™ for Nerve Repair Surgery

Orthocell achieves record growth with Striate+ and Remplir

Proactive Investors

Radiofrequency Ablation - Pros & Cons

Best Practice Health

Orthocell -Tendon Repair - 9 News 101221

Radiofrequency Ablation - Patient Experience

Sound Pain Alliance

Orthocell expands Remplir™ sales to Singapore

Proactive Investors

Supplementation For Nerve Regeneration - Accelerating Nerve Injury Recovery

Dr. Markle: Regenerative Orthopedics Expert

Orthocell’s Remplir™ added to Australian Prostheses list

Proactive Investors

Orthocell's Celgro™️ - Nerve repair

Orthocell (ASX: OCC) – Webinar presentation

Organotypic Spinal Cord cultures Grown on MEAs Regeneration Analysis | Protocol Preview

JoVE (Journal of Visualized Experiments)

Orthocell moves closer to US market clearance and sales

Proactive Investors

Update on Acute Management of Spinal Cord Injury

Endovascular thrombectomy superior to medical management for large core stroke in SELECT2